Should I Buy PHGE? PHGE 2026 Analysis

Should You Buy Biomx Inc (PHGE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

7.050

1 Day change

7.14%

52 Week Range

22.060

Analysis Updated At

2026/01/26

Biomx Inc (PHGE) is not a good buy for a beginner investor with a long-term strategy at this time. The company's financial performance is weak, with significant losses and no revenue growth. Technical indicators suggest the stock is overbought, and there are no significant positive catalysts or trading signals to support a buy decision. Additionally, the lack of recent news, neutral trading trends, and no congress trading data further reduce confidence in this stock as a long-term investment opportunity.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 95.075, signaling the stock is overbought. Moving averages are converging, suggesting indecision in the market. Key support and resistance levels are at S1: 2.15 and R1: 4.771, with the pre-market price at 3.9, close to resistance.

Options Data

Positive Catalysts

Analyst Joseph Pantginis from H.C. Wainwright raised the price target to $26 from $15, maintaining a Buy rating. This follows the company's reverse stock split.

Neutral/Negative Catalysts

Additionally, there is no recent news or significant trading trends to support a positive outlook.

Financial Performance

In Q3 2025, the company reported no revenue growth (0% YoY), a net income drop to -$9,166,000 (-195.06% YoY), and an EPS decline to -5.55 (-149.64% YoY). Gross margin remains at 0.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

H.C. Wainwright analyst Joseph Pantginis raised the price target to $26 from $15 and maintained a Buy rating. However, this is based on a reverse stock split rather than fundamental improvements in the company's performance.

1 Analyst Rating

Wall Street analysts forecast PHGE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PHGE is 26 USD with a low forecast of 26 USD and a high forecast of 26 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 6.580

Low

Averages

High

Current: 6.580

Low

Averages

High

H.C. Wainwright

Joseph Pantginis

Buy

upgrade

$15 -> $26

AI Analysis

2025-11-25

Reason

H.C. Wainwright

Joseph Pantginis

Price Target

$15 -> $26

AI Analysis

2025-11-25

upgrade

Buy

Reason

H.C. Wainwright analyst Joseph Pantginis adjusted the firm's price target on BiomX to $26 from $15 and keeps a Buy rating on the shares. The adjusted target follows the company's reverse stock split.

H.C. Wainwright

Joseph Pantginis

Buy

downgrade

$21 -> $15

2025-05-16

Reason

H.C. Wainwright

Joseph Pantginis

Price Target

$21 -> $15

2025-05-16

downgrade

Buy

Reason

H.C. Wainwright analyst Joseph Pantginis lowered the firm's price target on BiomX to $15 from $21 and keeps a Buy rating on the shares following the Q1 report.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for PHGE

Unlock Now

PHGE Should I Buy

PHGE Should I Buy

Should You Buy Biomx Inc (PHGE) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch